This compound is a leucine derivative featuring a fluorenylmethoxycarbonyl (Fmoc) protecting group and D-configuration stereochemistry. It serves as a building block in peptide synthesis, enabling the incorporation of D-leucine residues into peptide chains during solid-phase or solution-phase assembly.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 114360-54-2
Fmoc-L-cysteine
pharmaceutical intermediate
Fmoc-O-tert-butyl-D-serine
pharmaceutical intermediate
(S)-N-Fmoc-2-Thienylalanine
pharmaceutical intermediate
Fmoc-O-tert-butyl-D-threonine
pharmaceutical intermediate
(2R,3R)-3-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)-2-hydroxy-4-phenylbutanoic acid
pharmaceutical intermediate
(S)-1-(2-Bromophenyl)ethanol
pharmaceutical intermediate
(r)-2-chloro-1-(2,4-dichlorophenyl)ethanol
pharmaceutical intermediate
N-(2-Pyrazinylcarbonyl)-L-phenylalanine
pharmaceutical intermediate
(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methylpentanoic acid
CBPJQFCAFFNICX-LJQANCHMSA-N
CC(C)C[C@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13